Document:

Form of 2006 Equity Plan Award Agmt for Directors' Nonqualified Stock Options

 Exhibit 10.2 
 NB&T FINANCIAL GROUP, INC. 
 2006 EQUITY PLAN 
 AWARD AGREEMENT 
 (Directors’
Nonqualified Stock Option) 
 NB&T Financial Group, Inc., an Ohio corporation (the “Company”), hereby grants an option
(this “Option”) to purchase its common shares, without par value (the “Shares”), to the Optionee named below. The terms and conditions of this Option are set forth in this Agreement (which includes this cover sheet), in the
NB&T Financial Group, Inc. 2006 Equity Plan (the “Plan”) and in the Plan prospectus. Copies of the Plan and the Plan prospectus are attached. A copy of this Award Agreement must be signed and returned to the President or the Chief
Financial Officer of the Company at its executive offices within 60 days of the Option Grant Date or the Option will be deemed forfeited. 
 Option Grant
Date:
                                        

 Name of Optionee:
                                        

 Number of Shares Covered by Option:
                                        

 Exercise Price per Share:
$                    , which is intended to be not less than 100% of the Fair Market Value of the Shares on the Option Grant Date.

 Vesting Schedule: Subject to all of the terms and conditions set forth in this Agreement and the Plan, your right to purchase Shares under this
Option shall vest as follows: 
  

			
	 Number of Full Years Beginning After Grant Date
	  	 Cumulative Percentage
 Vested

	Less than 1	  	0 percent
	1 but fewer than 2	  	33 1/3 percent
	2 but fewer than 3	  	66 2/3 percent
	3 or more	  	100 percent

 Option Term: Ten years 
 By signing the cover sheet of this Agreement, the undersigned agree to all of the terms and conditions described in this Agreement and in the Plan. 
  

					
	 Optionee:
	 	  

		 	Signature
		
		 	  
 Typed or printed
name

			
	Company:	 	By	 	  

		 		 	Signature
		
		 	  
 Typed or printed
name

			
		 	Its	 	  

 The Plan and Other Agreements 
 The text of the Plan, as it may be amended from time to time, is incorporated in this Agreement by reference. This Agreement (which includes the cover sheet) and the Plan constitute the entire understanding between you and the Company
regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded. In the event that any provision in this Agreement conflicts with any term in the Plan, the term in the Plan shall be deemed controlling.
Certain capitalized terms used in this Agreement are defined in the Plan. You are strongly urged to read the Plan and the Plan prospectus in their entirety. 
 Nonqualified Stock Option 
 This Option is not intended to qualify as an Incentive Stock Option under section 422 of the Code and shall be
interpreted accordingly. 
 Vesting 
 This Option may be exercised according to the schedule set forth on the cover sheet. 
 Term 
 This Option shall expire in any event at the close of business at the Company’s executive offices on the day before the ten-year anniversary of the Option Grant
Date, as shown on the cover sheet. This Option will expire earlier if your service as a Director (“Service”) Terminates, as described below. 
 Termination due to Death or Disability 
 If your Service Terminates because of your death or Disability, this Option will expire at the close
of business at the Company’s executive offices on the earlier of the expiration date specified in this Award Agreement or one year after the date of death or disability. 
 Termination for Cause 
 If your service is Terminated, or is deemed to have been Terminated, for Cause, this Option
will immediately expire, and all unexercised rights to purchase Shares under this Agreement, whether or not then exercisable, will be forfeited. 
 Termination for Any Other Reason 
 If your Service Terminates for any reason other than because of your death of Disability or because you
were Terminated for Cause, this Option may be exercised to the extent it is exercisable at the date of Termination at any time before the earlier of (1) the expiration date specified in this Agreement or (2) 90 days after the Termination
date. To the extent this Option is not exercisable as of the date of Termination, the right to purchase Shares under this Option shall be forfeited. 
 Notice of Exercise 
 When you wish to exercise this Option, you must notify the Company by delivering an appropriate “Notice of
Exercise” to the Committee, in care of either the President or the Chief Financial Officer of the Company at the Company’s executive offices. A copy of such Notice of Exercise is attached to this Agreement. Your notice must specify how
many Shares you wish to purchase (which must be a whole number of Shares) and how your Shares should be registered (in our name only, or in your and your spouse’s names as joint tenants or as joint tenants with right of survivorship). Your
notice will be effective when it is received by the Company at the Company’s executive offices. If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled
to do so. 

 Form of Payment 
 When
you submit your notice of exercise, you must include payment of the Exercise Price per Share for the Shares you are purchasing. Payment may be made in cash, a cashier’s check or a money order, or you may exercise this Option by tendering Shares
you already have owned for at least six months and that have a Fair Market Value equal to the Exercise Price per Share for the Shares you are purchasing. You are urged to read carefully the taxation discussion in the Plan prospectus before
exercising your Option. 
 Withholding Taxes 
 You will
not be allowed to exercise this Option unless you make arrangements acceptable to the Committee to pay any withholding or other taxes that may be due as a result of the exercise of this Option or the sale of Shares acquired under this Option.

 Restrictions on Exercise and Resale 
 By signing this
Agreement, you agree not to exercise this Option or sell any Shares acquired under this Option at a time when applicable laws, regulations or Company or underwriter trading policies prohibit exercise, sale or issuance of Shares. The Company will not
permit you to exercise this Option if the issuance of shares at that time would violate any law or regulation. The Company shall have the right to designate one or more periods of time, each of which shall not exceed 180 days in length, during which
this Option shall not be exercisable if the Committee determines, in its sole discretion, that such limitation on exercise could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act of 1933, as amended (the
“Securities Act’), or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any issuance of securities by the Company under the Securities Act or any state
securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any state securities laws for the issuance or transfer of any securities. Such limitation on exercise shall
not alter the Vesting Schedule set forth on the cover page other than to limit the periods during which this Option shall be exercisable. 
 Transfer of
Option 
 Prior to your death, only you may exercise this Option and you may not transfer or assign this Option, except to the Company. 
 Beneficiary Designation 
 You may name a Beneficiary or Beneficiaries
to receive or to exercise this Option at your death, to the extent this Option is so exercisable as set forth elsewhere in this Agreement and the Plan. Such a designation may be done only on the attached Beneficiary Designation Form and by following
the rules in that Form. The Beneficiary Designation Form need not be completed now and is not required as a condition of receiving your Option. If you die without completing a Beneficiary Designation Form or if you do not complete that Form
correctly, your Beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate. 

 No Rights to Continue as Director 
 Neither this Option nor this Agreement gives you the right to continue as a Company director or to be nominated by the Board of Directors of the Company to continue as a Company director. 
 No Shareholder Rights 
 Neither you, nor your estate or heirs, shall
have any rights as a shareholder of the Company with respect to the Shares underlying this Option until this Option has been exercised and a certificate for the Shares being acquired has been issued. No adjustments will be made for dividends or
other rights if the applicable record date occurs before the certificate for the Shares is issued, except as described in the Plan. 
 Adjustments

 The Committee may adjust the number of Shares covered by this Option and the Exercise Price per Share under certain circumstances as provided in the
Plan. Notwithstanding anything to the contrary contained in this Agreement, this Option (and the vesting thereof) shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company becomes subject to
such corporate activity. The Committee also retains the right to amend the Plan and this Agreement without any additional consideration to you to the extent necessary to avoid penalties arising under Code Section 409A, even if those amendments
reduce, restrict or eliminate rights granted under the Plan or this Agreement (or both) before those amendments.Modification of Engagement Agreement

 Exhibit 10.99.3 
 MODIFICATION OF ENGAGEMENT AGREEMENT 
 This Modification of Engagement Agreement (“Modification
Agreement”) is entered into on March 10, 2006 between Silverwood Partners LLC (“Silverwood”) and Path 1 Network Technologies Inc. (“Path 1”). 
 This Modification Agreement relates to (1) an engagement letter agreement entered into between Silverwood and Path 1 on September 9, 2004 (the
“Engagement Agreement”) and (2) Path 1’s December 6, 2005 financing transactions (the “Laurus Transaction”) with Laurus Master Fund Ltd. (“Laurus”), pursuant to which Path 1 issued to Laurus
(i) a Secured Convertible Note in the principal amount of $2,100,000 (the “Laurus Note”), convertible into shares of Common Stock at an initial fixed conversion price equal to $2.6316, and (ii) Warrants exercisable at $2.89 per
share for the purchase of shares of Common Stock. Under the Laurus Note Path 1 must, in certain circumstances, make scheduled payments of principal and interest in shares of Common Stock. 
 On February 17, 2006, Silverwood filed a lawsuit (Silverwood Partners LLC vs. Path 1 Network Technologies Inc., No. 06 CA 10303 NMG (United
States District Court, District of Massachusetts) against Path 1 (the “Lawsuit”). 
 1. In exchange for Silverwood’s agreement to modify the
parties’ rights and obligations under the Engagement Agreement, as set forth in Paragraph 3 below, as follows: 
 a. Path 1 agrees to
issue the Modification Shares, as defined below, to Silverwood on the Request Date. The “Request Date” is the date on which Path 1, knowing that the SEC is prepared to declare effective a Form S-3 resale registration statement (as amended
through the Request Date) covering the Settlement Shares (and any other securities covered by such registration statement), requests that the SEC declare the registration statement effective two business days thereafter. The “Modification
Shares” are a number of shares of Path 1 Common Stock equal to $80,000 divided by the product of 0.75 times the closing sale price of Path 1 Common Stock on the second trading day before the Request Date. Path 1 agrees to file the registration
statement by no later than 14 days after the SEC declares the resale registration statement for Laurus’ underlying shares effective or, if earlier, by April 7, 2006. 
 b. Path 1 agrees to issue to Silverwood 31,920 Path 1 common stock warrants with an initial exercise price of $2.6316 per share, expiring on
December 6, 2013, in the form contemplated by the Engagement Agreement with regard to the Laurus Transaction. Silverwood hereby assigns and Path 1 agrees to transfer such warrants to Silverwood’s representatives in the amounts of:
Jonathan Hodson-Walker, 20,000 warrants, Nicolas A. McCoy 10,320 warrants and John C. Bowen 1,600 warrants. 
 2. In exchange for Silverwood’s agreement
to dismiss the Lawsuit with prejudice and to waive all claims that it may have with respect to the Laurus Transaction (all as set forth in further detail in paragraph 5 below), Path 1 agrees as follows: 
 a. Path 1 agrees to issue the Settlement Shares, as defined below, to Silverwood on the Request Date. The “Settlement Shares” are a number of
shares of Path 1 Common Stock equal to $20,000 divided by the product of 0.75 times the closing sale price of Path 1 Common Stock on the second trading day before the Request Date. Path 1 agrees to file the registration statement by no later than 14
days after the SEC declares the resale registration statement for Laurus’ underlying shares effective or, if earlier, by April 7, 2006. 

 b. Path 1 agrees to issue to Silverwood 7,980 Path 1 common stock warrants with an initial exercise price
of $2.6316 per share, expiring on December 6, 2013, in the form contemplated by the Engagement Agreement with regard to the Laurus Transaction. Silverwood hereby assigns and Path 1 agrees to transfer such warrants to Silverwood’s
representatives in the amounts of: Jonathan Hodson-Walker 5,000 warrants, Nicolas A. McCoy 2,580 warrants and John C. Bowen 400 warrants 
 3. Silverwood
agrees that until the Request Date it shall not, directly or indirectly, sell any Path 1 securities or establish or increase a short position in Path 1 securities, or induce anyone else to do so. Silverwood represents that it is acquiring the
Modification Shares and the Settlement Shares for investment and not with a view to distribution thereof. 
 4. The Engagement Agreement is amended so that
(a) Silverwood is entitled to no compensation or fees of any kind for any past or future Path 1 transaction except as have already been paid, or are expressly required by this Modification Agreement; (b) in the event of any Private
Placement from any entity on Schedule A of the List, as defined below, (other than as provided in Section 4(c) hereof)) which closes between the date hereof and June 24, 2006, Path 1 shall pay Silverwood 50% of the Cash Fee (up to a
maximum payment of $150,000) and 50% of the number of Warrants indicated by Section 2(b)(ii) of the Engagement Agreement (up to a maximum number of Warrants which corresponds to the $150,000 Cash Fee cap); (c) in the event that Silverwood
arranges a telephonic or physical meeting between an investor on Schedule B of the List and Path 1’s management which occurs within 14 days after the date of this Modification Agreement and a definitive agreement for a Private Placement from an
investor on Schedule B of the List is signed between the date hereof and June 24, 2006, Path 1 shall pay Silverwood the full indicated Cash Fee and Warrants for such Private Placement from such investor; and (d) in the event of any Sale
which closes between today and June 24, 2006, Path 1 shall pay Silverwood 50% of the Success Fee (up to a maximum of $150,000). As so amended, the Engagement Agreement shall survive this Modification Agreement, it being understood that in no
event shall any compensation be payable for any transaction which closes after June 24, 2006, unless otherwise agreed in writing hereafter by the parties hereto. The List means the list, delivered by Silverwood to Path 1 on March 10, of
(i) certain entities as to which Silverwood advised Path 1 before June 24, 2005 or to whom Path 1 proposed, and (ii) certain entities with whom Path 1 held discussions regarding, a Private Placement, Sale or other transaction between
September 9, 2004 and June 24, 2005. 
  

	5.	(a) Silverwood agrees to forthwith dismiss the Lawsuit with prejudice. 

 (b) Silverwood agrees never under any circumstance to refile in any court the Lawsuit, nor file any litigation which includes any Silverwood Claims (as defined below). Silverwood releases Path 1 and its officers,
directors, employees, agents, attorneys, stockholders, lenders, affiliates, insurers, successors and assigns, from all causes of action, lawsuits, claims, demands, charges, liabilities or complaints of whatever kind, present or future, known or
unknown (the “Silverwood Claims”). Provided, however, that the Silverwood Claims expressly do not include (i) Claims arising under this Modification Agreement, (ii) Claims arising under warrants previously issued by Path 1 to
Silverwood or its designees under the Engagement Agreement, or (iii) future Claims (i.e., claims arising after the date of this Modification Agreement) arising under the Engagement Agreement (as amended herein). Silverwood
acknowledges that it may hereafter 

 discover facts different from, or in addition to, those which it now knows or believes to be true with respect to all or
any of the Silverwood Claims. Nevertheless, Silverwood agrees that the release set forth herein shall be and remain effective in all respects, notwithstanding the discovery of such additional or different facts. 
  
 (c) Path 1 agrees never under any circumstance to file any litigation which
includes any Path 1 Claims (as defined below). Path 1 releases Silverwood and its members, managers, constituent partners, officers, directors, employees, agents, attorneys, stockholders, lenders, affiliates, insurers, successors and assigns, from
all causes of action, lawsuits, claims, demands, charges, liabilities or complaints of whatever kind, present or future, known or unknown (the “Path 1 Claims”). Provided, however, that the Path 1 Claims expressly do not include
(i) Claims arising under this Modification Agreement or (ii) future Claims (i.e., claims arising after the date of this Modification Agreement) arising under the Engagement Agreement (as amended herein). Path 1 acknowledges that it
may hereafter discover facts different from, or in addition to, those which it now knows or believes to be true with respect to all or any of the Path 1 Claims. Nevertheless, Path 1 agrees that the release set forth herein shall be and remain
effective in all respects, notwithstanding the discovery of such additional or different facts. 
  
 (d) Each party shall bear its own expenses in connection with the Lawsuit and in connection with this Modification Agreement. The parties agree that if
either of them breaches the terms of this Modification Agreement, the other party would be irreparably injured, and in the event of such breach the other party shall be entitled to temporary, preliminary and permanent injunctive relief, specific
performance and other equitable remedies, in addition to any and all remedies at law for such breach. 
  
 (e) Silverwood represents that it has not previously assigned, and covenants that it never will assign, any Silverwood Claims to anybody other than as
previously agreed between the parties hereto or as agreed herein. Path 1 represents that it has not previously assigned, and covenants that it never will assign, any Path 1 Claims to anybody. 
  
 (f) Each of the parties expressly waives any and all rights and benefits
conferred upon it by Section 1542 of the Civil Code of the State of California (and under all similar statutes and common-law principles of all jurisdictions), which states as follows: 
  
 “A general release does not extend to claims which
the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.” 
  
 6. This Modification Agreement shall be governed by and construed in accordance with the laws
of the Commonwealth of Massachusetts. This Modification Agreement cannot be amended, terminated or waived except in a writing signed by both parties. Each party represents and warrants that no promise, inducement or agreement not expressed herein
has been made to it in connection with this Modification Agreement. This Modification Agreement contains the entire agreement between the parties with respect to the subject matter of the Lawsuit, the Engagement Agreement, the Silverwood Claims and
the Path 1 Claims and supersedes any previous agreement between the parties with regard to the subject matter hereof. 

 7. This Modification Agreement shall be binding upon the parties hereto and their assigns and successors, and shall inure
to the benefit of the parties hereto and their assigns and successors and the other releasees described herein and their respective assigns and successors. 
 8. Silverwood may, in accordance with the Engagement Agreement, at its option and expense, place an announcement on its Web site, in Silverwood marketing materials and in such newspapers and periodicals as Silverwood may select that
includes Path 1 press release information, Path 1’s logo and customary “tombstone” information for the Series A Preferred Stock Financing, the Series B Preferred Stock financing and the Laurus Transaction. 
 9 . This Modification Agreement may be executed in counterparts. This Modification Agreement may be executed by facsimile transmission. 
  

			
	 PATH 1 NETWORK TECHNOLOGIES INC.

		
	 By:
	 	 /s/ Tom Tullie

		 	 Tom Tullie

		 	 Chief Executive Officer

	
	 SILVERWOOD PARTNERS LLC

		
	 By:
	 	 /s/ Jonathan Hodson-Walker

		 	Jonathan Hodson-Walker
		 	Managing Partner

 I agree that I am acquiring the warrants described above, and would acquire the underlying shares, for
investment and not with a view to distribution thereof. 
  

	
	 /s/ Jonathan Hodson-Walker    

	 Jonathan Hodson-Walker

	  
 /s/ Nicolas A.
McCoy    

	 Nicolas A. McCoy

	  
 /s/ John C.
Bowen    

	 John C. Bowen

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]